Risk of stroke greater for women than men among older patients diagnosed with atrial fibrillation
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke ...
Cardiology
May 08, 2012 |
not rated yet |
0
|
Stroke risk high when anti-clotting drugs stopped
Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging ...
Cardiology
Apr 25, 2012 |
not rated yet |
0
Innovations in anticoagulation for stroke prevention
New scientific findings in anticoagulation for stroke prevention are paving the way for updates to the European Society of Cardiology (ESC) Guidelines for the management of atrial fibrillation.
Cardiology
Jun 13, 2012 |
not rated yet |
0
Study: Blood transfusion associated with increased risk of death for patients with heart attack
A meta-analysis of 10 studies suggests that receipt of a blood transfusion among patients with myocardial infarction (heart attack) was associated with increased all-cause mortality compared with not receiving a blood transfusion ...
Cardiology
Dec 24, 2012 |
not rated yet |
0
|
Quick-reversal method may be at hand for new blood thinner
(HealthDay) -- Newer blood-thinning drugs sometimes have one drawback: In cases where they trigger bleeding, their effects can be tough to reverse compared to the standard anticoagulant, warfarin.
Medications
Jun 20, 2012 |
not rated yet |
0
|
Clot-busting medicine safe for use in warfarin-treated patients following stroke
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI). This ...
Cardiology
Jun 26, 2012 |
not rated yet |
0
|
Safety indicators confirmed for common treatment of heart defect
A new study by medical scientists coordinated from the University of Manchester has for the first time used patients' results to establish that "safety indicators" for people taking anticoagulant drugs to regulate a common ...
Cardiology
Jul 03, 2012 |
not rated yet |
0
Higher risk of VTE in CKD surgical patients on enoxaparin
(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin ...
Diseases, Conditions, Syndromes
Jun 08, 2012 |
not rated yet |
0
Rituximab shows promise for clinical problems tied to antiphospholipid antibodies
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease ...
Arthritis & Rheumatism
Nov 20, 2012 |
not rated yet |
0
|
Study finds warfarin underutilized in women
Dr. Rabab Mohsin, an internal medicine resident at the University of Kentucky, working with Dr. Alison Bailey of the University of Kentucky Gill Heart Institute, has discovered that the drug warfarin was underutilized in ...
Medications
Dec 13, 2011 |
not rated yet |
0
Study examines anticoagulation treatment following aortic valve replacement
Although current guidelines recommend 3 months of anticoagulation treatment after bioprosthetic aortic valve replacement surgery, a study that included more than 4,000 patients found that patients who had warfarin therapy ...
Cardiology
Nov 27, 2012 |
not rated yet |
0
|
FDA: Pradaxa not for patients with mechanical heart valves
(HealthDay)—The blood thinner Pradaxa should not be used to prevent stroke or blood clots in patients with mechanical heart valves, the U.S. Food and Drug Administration said in a warning issued Wednesday.
Cardiology
Dec 21, 2012 |
not rated yet |
0
Venous thromboembolism risk up with cisplatin-based chemo
(HealthDay)—Patients with advanced solid tumors receiving cisplatin-based chemotherapy regimens have a significantly higher risk of having a venous thromboembolic event (VTE) compared with those who do ...
Cancer
Nov 15, 2012 |
not rated yet |
0
Raised risk of ischemic stroke in women with A-fib explored
(HealthDay)—Women with atrial fibrillation (AF) have a higher risk of ischemic stroke than men with AF, related in part to differences in the percent time in the therapeutic range (TTR) associated with ...
Cardiology
Dec 10, 2012 |
not rated yet |
0
West Nile virus: Be smart, don't panic
The current outbreak of West Nile virus may prove to be the worst since the disease was first recorded in New York 13 years ago, and it shows no indication of slowing down. As of the beginning of this month, ...
Diseases, Conditions, Syndromes
Sep 05, 2012 |
5 / 5 (1) |
0
